Gut Microbiome Recovery After Polyp Removal May Take a Decade

Removal of colorectal polyps is linked to gut microbiome disruptions that can persist for more than 10 years, according to research reported by ScienceAlert. The findings suggest that the microbial environment in the colon may remain altered long after the physical polyp is removed, potentially influencing long-term health risks.

The research indicates that the composition of bacteria in the gut does not simply return to a baseline state following a polypectomy. Instead, a distinct microbial signature remains, distinguishing those who have had polyps removed from those who have not, even a decade later.

How does polyp removal affect the gut microbiome?

A polypectomy involves the surgical removal of a growth from the lining of the colon. According to the reporting by ScienceAlert, this process, combined with the intensive bowel preparation required for colonoscopies, triggers a significant shift in the gut’s bacterial ecology.

Bowel preparation typically involves strong laxatives that flush the colon. This creates an acute disruption by removing a vast quantity of resident microbes. While many bacterial populations recover quickly, the study suggests that certain shifts are permanent or long-lasting.

The resulting “disrupted” state is characterized by a different balance of bacterial species compared to individuals who never developed polyps. This suggests that the removal of the polyp does not necessarily remove the biological environment that allowed the polyp to form.

Why do these changes last for over a decade?

Researchers suggest the long-term disruption may be due to the relationship between the microbiome and the host’s genetics or lifestyle. The bacteria that persist after a polypectomy may be the same types of bacteria that contributed to the initial growth of the polyp.

If the underlying factors—such as diet, inflammation, or genetic predisposition—remain unchanged, the gut microbiome may continue to favor a “pro-polyp” environment. In this context, the disruption is not a side effect of the surgery itself, but a reflection of a chronic biological state.

This contrasts with other medical disruptions, such as short-term antibiotic use, where the microbiome often returns to its original state within several months. The decade-long persistence observed in polyp patients indicates a more fundamental shift in the colonic ecosystem.

What are the implications for colorectal cancer screening?

The persistence of these microbial changes suggests that the microbiome could serve as a biomarker for future risk. If a patient’s gut remains in a disrupted state, they may be more susceptible to developing new polyps, regardless of the successful removal of previous ones.

Current screening protocols focus on the physical removal of polyps to prevent colorectal cancer. However, the ScienceAlert report highlights a gap in this approach: the physical removal of the growth does not address the microbial imbalance.

Medical researchers are now looking into whether modulating the microbiome could reduce the recurrence of polyps. This could involve targeted dietary changes or other interventions to shift the microbiome away from the disrupted state identified in the study.

What remains uncertain about microbiome recovery?

It remains unclear whether the disrupted microbiome actively causes new polyps to grow or if it is simply a passive indicator of a high-risk environment. The study establishes a correlation between the long-term microbial shift and a history of polyps, but it does not definitively prove that the bacteria themselves drive the growth.

Additionally, the research does not specify a universal “healthy” microbiome that all patients should aim to recover. Because gut flora varies significantly between individuals, researchers must determine what constitutes a “disrupted” state for a specific person versus a natural variation.

Future studies are expected to examine whether specific strains of bacteria can be reintroduced to “reset” the microbiome after a polypectomy to lower the risk of recurrence.